Influence of apolipoprotein E genotype on neuronal damage and ApoE immunoreactivity in human hippocampus following global ischemia

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 3, 1999, Pages 227-234

  Horsburgh, Karen ^a   Graham, David I ^a   Stewart, Janice ^a   Nicoll, James A R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Apolipoprotein E; Cardiorespiratory arrest; Genotype; Human; Immunoreactivity; Ischemia

Indexed keywords

APOLIPOPROTEIN E4;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NERVE CELL LESION; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 0033041272     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199903000-00002     Document Type: Article

References (32)

1. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72
2. Teasdale GM, Nicoll JAR, Fiddes M, Murray G. Association of apoE polymorphism with outcome after head injury. Lancet 1997;350:1069-71
3. Alberts MJ, Graffagnino C, McClenny C, et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet 1995;346:575
4. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S. Apolipoprotein E epsilon-4 associated with chronic traumatic brain injury in boxing. JAMA 1997;278:136-40
5. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30
6. Poirier J, Baccichet A, Dea D, Gauthier S (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 1993;55:81-90
7. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. T.I.N.S. 1994;17:525-30
8. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985;76:1501-13
9. Horsburgh K, Nicoll JAR. Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat. Neuropathol Appl Neurobiol 1996a;22:342-49
10. Horsburgh K, Nicoll JAR. Selective cellular alterations in amyloid precursor protein and apolipoprotein E following transient global ischaemia in the rat. Alz Res 1996b;2:37-42
11. Horsburgh K, Fitzpatrick M, Nilsen M, Nicoll JAR. Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural hematoma in rat. Brain Res 1997;763: 103-10
12. Hall ED, Oostveen JA, Dunn E, Carter DB. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 1995;135:17-27
13. Kida E, Pluta R, Lossinsky AS, et al. Complete cerebral ischemia with short term survival in rat induced by cardiac arrest. Extracellular and intracellular accumulation of apolipoprotein E and J in brain. Brain Res 1995;674:341-46
14. Han SH, Einstein G, Weisgraber KH, et al. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J Neuropathol Exp Neurol 1994b;53: 535-44
15. Metzger RE, LaDu MJ, Pan JB, Getz GS, Frail DE, Falduto MT. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: Implications for Alzheimer's disease. J Neuropath Exp Neurol 1996;55:372-80
16. Han SH, Hulette C, Saunders AM, et al. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol 1994a;128: 13-26
17. Nicoll JAR, Horsburgh K, Graham DI. Increased neuronal apoE immunoreactivity after acute brain injury due to hypoxia/ischaemia, hypoglycaemia, and status epilepticus. J Neurotrauma 1998;15:52
18. Fleming LM, Weisgraber KH, Strittmatter WJ, Troncoso JC, Johnson GV. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp Neurol 1996;138:252-60
19. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc Natl Acad Sci USA 1994;91:11183-86
20. Nicoll JAR, Burnett C, Love S, et al. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997;41:716-21
21. Graham DI. Hypoxia and vascular disorders. In: Adams JH, Duchen LW, Edward A eds. Greenfields neuropathology, London 1992; 153-268
22. Schmechel DE, Tiller MO, Tong P et al. Pattern of Apolipoprotein E immunoreactivity during brain aging. In: Roses AD, Weisgraber KH, Christen Y, eds. Apolipoprotein E and Alzheimer's disease. Fondation IPSEN. Berlin: Springer-Verlag, 1996:29-48
23. Poirier J, Hess M, May PC, Finch CE. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 1991;11:97-106
24. Pluta R, Lossinsky AS, Wisniewski HM, Mossakowski MJ. Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest. Brain Res 1994;633: 41-52
25. Sorbi S, Nacmias B, Piacentini S et al. ApoE as a prognostic factor for post-traumatic coma. Nature Med 1995;1:852
26. Tardiff B, Newman B, Saunders A. Apolipoprotein E allele frequency in patients with cognitive defects following cardiopulmonary bypass, Circulation 1994;90:1-204
27. Ikeda K, Aizawa T, Haga S et al. Very low density lipoprotein receptor and Alzheimer's disease. In: Roses AD, Weisgraber KH and Christen Y, eds. Apolipoprotein E and Alzheimer's disease. Berlin Heidelberg: Springer,Verlag, 1996:59-73
28. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 1993;11:575-80
29. Kowal RC, Herz J, Wiesgraber KH. Opposing effects of apolipoprotein E and C on lipoprotein binding to low density lipoprotein receptor-related proteins. J Biol Chem 1990;265:10771-79
30. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994;264:850-52
31. Xu P, Schmechel D, Rothrock-Christian T, et al. Human apolipoprotein E2, E3, and E4 isoform specific transgenic mice: Human-like pattern of neuronal immunoreactivity in central nervous system not observed in wildtype mice. Neurobiol Dis 1996;3:229-45
32. Sun Y, Wu S, Bu G, et al. Glial fibrillary acidic-protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci 1998;16:3261-72